We have used chemical shift perturbation (CSP) and saturation
transfer
difference (STD) NMR experiments to identify and characterize the
binding of selected ligands to the receptor-binding domain (RBD) of
the spike glycoprotein (S-protein) of the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). We also subjected full-length
S-protein to STD NMR experiments, allowing correlations with RBD-based
results. CSPs reveal the binding sites for heparin and fondaparinux,
and affinities were measured using CSP titrations. We then show that
α-2,3-sialyllactose binds to the S-protein but not to the RBD.
Finally, combined CSP and STD NMR experiments show that lifitegrast,
a compound used for the treatment of dry eye, binds to the linoleic
acid (LA) binding pocket with a dissociation constant in the μM
range. This is an interesting finding, as lifitegrast lends itself
well as a blueprint for medicinal chemistry, eventually furnishing
novel entry inhibitors targeting the highly conserved LA binding site.